{"id":431826,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-12-18] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T06:45:34.502000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-12-18.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-12-18] December 18, 2025 Our file number: 25-108167-776 The purpose of this Notice of Amendment is to announce the addition of bempedoic acid, bexagliflozin, izenivetmab, lecanemab, oritavancin, pirtobrutinib,…","rawSnapshotUrl":"/api/snapshots/raw/431826","browseUrl":"https://replay.healtharchive.ca/job-6/20260102064534/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-12-18.html#ha_snapshot=431826","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}